Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.

@article{Ghosh2019AlternativesTC,
  title={Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.},
  author={Chandradhish Ghosh and Paramita Sarkar and R Issa and Jayanta Haldar},
  journal={Trends in microbiology},
  year={2019},
  volume={27 4},
  pages={
          323-338
        }
}
As more antibiotics are rendered ineffective by drug-resistant bacteria, focus must be shifted towards alternative therapies for treating infections. Although several alternatives already exist in nature, the challenge is to implement them in clinical use. Advancements within biotechnology, genetic engineering, and synthetic chemistry have opened up new avenues towards the search for therapies that can substitute for antibiotics. This review provides an introduction to the various promising… 

Figures, Tables, and Topics from this paper

Alternative therapeutic approaches in the era of antimicrobial resistance: An overview
  • T. Dutta
  • Medicine
    Indian Journal of Animal Health
  • 2020
TLDR
The article is focused on the major breakthrough on new or renewed technologies published in various parts of the world on non-antibiotic antimicrobial agents as potential alternative therapeutic approaches.
Antimicrobial peptides as a potent therapeutic regimen to quench biofilm-mediated antimicrobial resistance
TLDR
Though peptide research is progressing day by day, their potential and practical application in the present-day clinical settings remains challenging.
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.
TLDR
An overview of antibiotics era, mode of actions of antibiotics, development and mechanisms of antibiotic resistance in bacteria, and future strategies to fight the emerging antimicrobial resistant threat are spotlighted.
Bacterial Resistance: antibiotics of last generation used in clinical practice and the arise of natural products as new therapeutic alternatives.
TLDR
A compilation on the chemical characteristics, efficiency, harmful outcomes and resistance mechanisms developed by the microorganisms can be consulted in the following sections together with a critical discussion, in line with the recent approaches.
Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action
TLDR
The advent of and the mechanisms that lead to antibiotic resistance will be described, and HDP mechanisms of antibacterial and immunomodulatory action will be presented, with specific examples of how the HDP aurein 2.2 and a few of its derivatives, namely peptide 73 and cG4L73, function.
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
TLDR
Novel uses of engineered phages not only for killing pathogenic bacteria, but also for in situ modification of human microbiota to attenuate symptoms of certain bacterial diseases and metabolic, immune, or mental disorders are summarized.
Lipidation of Antimicrobial Peptides as a Design Strategy for Future Alternatives to Antibiotics
TLDR
Analysis of lipidated analogs of 66 different HDPs suggests that lipidated HDPs with improved activity over the nonlipidated counterpart had acyl chain lengths of 8–12 carbons, and active lipidated peptides attached to short HDPs tended to have longer acylchain lengths.
The role of vaccines in combating antimicrobial resistance (AMR) bacteria
TLDR
The overall advantages of vaccination as an anti-antimicrobial resistance approach are quantified, the existing antimicrobial vaccines and those currently under development are analyzed, and some of the obstacles and prospects of vaccine research and development are emphasized.
An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections
TLDR
This review focuses on antimicrobial peptides (AMPs), especially those with a high potential of efficacy against multidrug-resistant and biofilm-forming bacteria and fungi present in wound infections.
Last Call for Replacement of Antimicrobials in Animal Production: Modern Challenges, Opportunities, and Potential Solutions
TLDR
An overview of the drug resistance phenomenon and its determinants, the steps taken to solve the problem, including the introduction of alternatives to antimicrobials, and the evaluation of some factors influencing the potential implementation of alternatives in animal production are presented.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 129 REFERENCES
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
TLDR
This review focuses on several ways and future directions to search for the next generation of safe and effective antibiotics compounds including antimicrobial peptides, phage therapy, phytochemicals, metalloantibiotics, lipopolysaccharide, and efflux pump inhibitors to control the infections caused by MDR pathogens.
Antimicrobial Peptides Under Clinical Trials.
TLDR
Clinical trials steps are defined and current status of several antimicrobial peptides under clinical development are described as well as briefly depict peptide drug formulation.
Bacteriocins — a viable alternative to antibiotics?
TLDR
Although the application of specific bacteriocins might be curtailed by the development of resistance, an understanding of the mechanisms by which such resistance could emerge will enable researchers to develop strategies to minimize this potential problem.
Modulating immunity as a therapy for bacterial infections
TLDR
A range of potential immune modulators have been proposed, including innate defence regulator peptides and agonists of innate immune components such as Toll- like receptors and NOD-like receptors, which could enhance protective antimicrobial immunity while limiting inflammation-induced tissue injury.
Synthetic biology platform technologies for antimicrobial applications.
TLDR
This review highlights emerging synthetic biology platform technologies that are geared toward the generation of new antimicrobial therapies, diagnostics, and discovery channels and the development of paper-based, cell-free expression systems holds promise in promoting the clinical translation of molecular biology tools for diagnostic purposes.
Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies.
TLDR
This work shows that targeted, engineered phagemid therapy can serve as a viable, nonantibiotic means to treat bacterial infections, while avoiding the health issues inherent to lytic and replicative bacteriophage use.
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
TLDR
An overview of the biological role, classification, and mode of action of AMPs is provided, the opportunities and challenges to develop these peptides for clinical applications are discussed, and the innovative formulation strategies for application are reviewed.
Bacteriophage therapy: a regulatory perspective.
TLDR
A multistakeholder meeting held at the EMA outlined the existing regulatory framework to which bacteriophage therapy should adhere and reviewed the current obstacles and shortcomings in scientific development.
Modifying natural antimicrobial peptides to generate bioinspired antibiotics and devices.
TLDR
The emergence of antibiotic resistance has increased impetus for the development of novel potent antibiotics and as result, antimicrobial peptides (AMPs) have been identified as promising candidate molecules, due to their unusual mechanisms of action and lack of side effects.
Small molecular antibacterial peptoid mimics: the simpler the better!
TLDR
A series of small molecular antibacterial peptoid mimics which exhibit high in vitro potency against a variety of Gram-positive and Gram-negative bacteria, including drug-resistant species such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium are presented.
...
1
2
3
4
5
...